AmbioPharm, a global peptide CDMO, was founded in 2005 and is headquartered in North Augusta, South Carolina, USA specializing in developing highly efficient manufacturing processes for peptide-based Active Pharmaceutical Ingredients (APIs) at small to very large scales. In our manufacturing facilities in South Carolina, USA and Shanghai, China, we manufacture New Chemical Entities (NCEs) under cGMP for clients worldwide. Both facilities have been inspected multiple times by the FDA with excellent outcomes.
View Top Employees from AmbioPharm - A Global Peptide CDMOWebsite | https://www.ambiopharm.com |
Revenue | $36.9 million |
Employees | 192 (192 on RocketReach) |
Founded | 2005 |
Address | 1024 Dittman Court, North Augusta, South Carolina 29842, US |
Phone | (803) 442-7590 |
Fax | (415) 921-3593 |
Technologies |
JavaScript,
HTML,
PHP
+44 more
(view full list)
|
Industry | Pharmaceutical Manufacturing, Pharmaceuticals, Healthcare |
Keywords | Pharmaceutical Manufacturing, Active Pharmaceutical Ingredients, Contract Manufacturing, Pharmaceutical Development |
Competitors | Apicore US LLC, Cedarburg Pharmaceuticals, A Division of AMRI, Phebra Pty Ltd, PolyPeptide Laboratories B.V., 浜理薬品工業(株) |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular AmbioPharm - A Global Peptide CDMO employee's phone or email?
The AmbioPharm - A Global Peptide CDMO annual revenue was $36.9 million in 2024.
Tim Nieters is the CEO of AmbioPharm - A Global Peptide CDMO.
192 people are employed at AmbioPharm - A Global Peptide CDMO.
AmbioPharm - A Global Peptide CDMO is based in North Augusta, South Carolina.
The NAICS codes for AmbioPharm - A Global Peptide CDMO are [32, 3254, 32541, 325].
The SIC codes for AmbioPharm - A Global Peptide CDMO are [283, 28].